Imported cutaneous gnathostomiasis: report of five cases.
Gnathostomiasis has rarely been described outside endemic countries. We report on a series of 5 patients (4 females, 1 male, mean age 42.2 years) who returned to France from South-East Asia and presented with cutaneous gnathostomiasis. The cutaneous lesions appeared within a mean period of 62 d (range 10-150 d) after return. They consisted of creeping eruptions in 3 patients (in addition one also had papules, one had nodules and hepatitis, and one had hepatitis; all 3 had profound asthenia) and recurring migratory swellings in 2 patients. The mean eosinophil count was 1546/mm3 (range 398-3245/mm3). Diagnosis was based on positive serological tests in 3 patients and seroconversion in 2 patients, and was confirmed by identification of Gnathostoma hispidum in a biopsy specimen from one of the seropositive patients. Albandazole (1-4 courses) was given as treatment. Recurrences may occur up to 24 months after apparent cure without reinfection. Gnathostomiasis should be considered when patients return from tropical countries and present with migratory swellings or creeping eruption that does not respond to the usual treatment for cutaneous larva migrans. Serological tests may be negative initially and thus need to be repeated to check for seroconversion. Treatment may require multiple courses of albendazole and a prolonged period of follow-up is necessary before cure can be confirmed.
Service des Maladies Infectieuses et Tropicales, Hôpital Nord, Marseille, France.
A
A
Ménard
G
G
Dos Santos
P
P
Dekumyoy
S
S
Ranque
J
J
Delmont
M
M
Danis
F
F
Bricaire
E
E
Caumes
D000328:Adult; D015766:Albendazole / Q000627:therapeutic use; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D005260:Female; D005602:France / Q000453:epidemiology; D006039:Gnathostoma; D006801:Humans; D007815:Larva Migrans / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D008297:Male; D017205:Spirurida Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D014195:Travel
D000871:Anthelmintics; D015766:Albendazole